[go: up one dir, main page]

NO922136L - Anvendelse av gibberelliner for behandling av prostatitisog psoriasis - Google Patents

Anvendelse av gibberelliner for behandling av prostatitisog psoriasis

Info

Publication number
NO922136L
NO922136L NO92922136A NO922136A NO922136L NO 922136 L NO922136 L NO 922136L NO 92922136 A NO92922136 A NO 92922136A NO 922136 A NO922136 A NO 922136A NO 922136 L NO922136 L NO 922136L
Authority
NO
Norway
Prior art keywords
psoriasis
treatment
prostatities
gibberellines
prostatitis
Prior art date
Application number
NO92922136A
Other languages
English (en)
Other versions
NO922136D0 (no
Inventor
Per Oden
Original Assignee
Per Oden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Per Oden filed Critical Per Oden
Publication of NO922136D0 publication Critical patent/NO922136D0/no
Publication of NO922136L publication Critical patent/NO922136L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P27/00—Preparation of compounds containing a gibbane ring system, e.g. gibberellin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Anvendelse av aktive gibberelliner for fremstilling av en farmasøytisk sammensetning for behandling av prostatltis og/eller psoriasis.
NO92922136A 1989-12-12 1992-05-29 Anvendelse av gibberelliner for behandling av prostatitisog psoriasis NO922136L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK627289A DK627289D0 (da) 1989-12-12 1989-12-12 Anvendelse af bicyclononanderivater
PCT/SE1990/000815 WO1991008751A1 (en) 1989-12-12 1990-12-10 The use of gibberellins for the treatment of prostatitis and psoriasis

Publications (2)

Publication Number Publication Date
NO922136D0 NO922136D0 (no) 1992-05-29
NO922136L true NO922136L (no) 1992-05-29

Family

ID=8148421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922136A NO922136L (no) 1989-12-12 1992-05-29 Anvendelse av gibberelliner for behandling av prostatitisog psoriasis

Country Status (11)

Country Link
EP (1) EP0504254B1 (no)
JP (1) JPH05502227A (no)
KR (1) KR920703088A (no)
AT (1) ATE136465T1 (no)
AU (1) AU648529B2 (no)
CA (1) CA2069002A1 (no)
DE (1) DE69026511T2 (no)
DK (1) DK627289D0 (no)
ES (1) ES2087279T3 (no)
NO (1) NO922136L (no)
WO (1) WO1991008751A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629318A (en) * 1992-12-18 1997-05-13 Merck & Co., Inc. Method of treatment of chronic prostatitis with 17β-N-monosubstituted-carbamoyl-4-aza-5α-androst-1-en-3-ones
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
FR2707646A1 (fr) * 1993-07-15 1995-01-20 Univ Toulouse Procédé d'extraction et de purification de saponines hémolytiques.
JP4234198B2 (ja) * 1995-01-06 2009-03-04 オーストラリアン・バイオメディカル・カンパニー・プロプライアタリー・リミテッド 獣医学および医学用途用化合物
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
AU2003299660A1 (en) * 2002-12-16 2004-07-22 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
JP5615484B2 (ja) * 2008-01-15 2014-10-29 株式会社 エス・ネット ５α‐リダクターゼ阻害剤
CN102526254B (zh) * 2012-02-08 2013-12-18 李宁 一种治疗男性前列腺炎的中药组合物
JP6761705B2 (ja) * 2016-02-01 2020-09-30 株式会社日本健康食品研究所 ５α−リダクターゼ阻害剤及び泌尿器系疾患治療・予防用組成物ならびにこれらの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424232A (en) * 1982-05-19 1984-01-03 Parkinson Richard W Treatment of herpes simplex

Also Published As

Publication number Publication date
NO922136D0 (no) 1992-05-29
CA2069002A1 (en) 1991-06-13
ES2087279T3 (es) 1996-07-16
DE69026511T2 (de) 1996-11-21
AU6913891A (en) 1991-07-18
KR920703088A (ko) 1992-12-17
DE69026511D1 (de) 1996-05-15
JPH05502227A (ja) 1993-04-22
EP0504254B1 (en) 1996-04-10
EP0504254A1 (en) 1992-09-23
DK627289D0 (da) 1989-12-12
ATE136465T1 (de) 1996-04-15
WO1991008751A1 (en) 1991-06-27
AU648529B2 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
IT9047580A0 (it) Procedimento di trattamento di polveri inorganiche.
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO922136D0 (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
NO900919D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske etere.
NO904800L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamater.
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO920983L (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
NO900972L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
SE8900564D0 (sv) Novel medicinal use
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
GR3005231T3 (no)
SE8802040D0 (sv) New use
ITMI941541A0 (it) Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono questi composti
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.
NO902968L (no) Fremgangsmaate for behandling av boreslam.
ITBO920160A0 (it) Composizione e procedimento per il trattamento dei tessuti